13 results
·
23ms
·
Sources: EU EUDAMED, US FDA
Filters
Regulation: Us FDA
×
LIQUICHEK ANTI-SM CONTROL, POSITIVE, CATALOG #115
FDA 510(k)
FDA Class 2
·Immunology
RPI SKIN OR AIR TEMPERATURE PROBE
FDA 510(k)
FDA Class 2
·General Hospital
SMARTWIRE/SMARTMAP PRESSURE SYSTEM
FDA 510(k)
FDA Class 2
·Cardiovascular
POWERED WHEELCHAIR
FDA Adverse Event
Malfunction
·INVACARE TAYLOR STREET·Product code ITI·March 27, 2013
HEARTMATE II LVAS
FDA Adverse Event
Injury
·THORATEC CORPORATION·Product code DSQ·March 18, 2011
AED
FDA Adverse Event
Malfunction
·WELCH ALLYN PROTOCOL, INC.·Product code MKJ·March 27, 2008
AIMING ARM/ RADIOLUCENT
FDA Adverse Event
Malfunction
·SYNTHES GMBH·Product code JDS·January 29, 2025
AIM-ARM RADIOLUC
FDA Adverse Event
Malfunction
·WRIGHTS LANE SYNTHES USA PRODUCTS LLC·Product code JDS·March 30, 2022
AIMING ARM/ RADIOLUCENT
FDA Adverse Event
Malfunction
·SYNTHES GMBH·Product code JDS·December 29, 2022
AIMING ARM/ RADIOLUCENT
FDA Adverse Event
Malfunction
·SYNTHES GMBH·Product code HWC·September 19, 2022
AIMING ARM/ RADIOLUCENT
FDA Adverse Event
Malfunction
·WRIGHTS LANE SYNTHES USA PRODUCTS LLC·Product code JDS·January 12, 2022
Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone
FDA Enforcement
Class II
·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012
CADD-Solis VIP ambulatory Infusion Pumps, Model 2110. Indicated for the following uses: Intra-arterial, subcutaneous, intraperitoneal, in close proximity to nerves, into an intraoperative site, epidural space or subarachnoid space. Therapies that require a continuous rate of infusion, intermittent bolus, and/or with patient-controlled demand doses.
FDA Enforcement
Class I
·Ongoing·Smiths Medical ASD Inc.·August 14, 2024